Partial reprogramming reveals lineage-specific uncoupling of rejuvenation, function, and recoverability in human cells

Partial reprogramming is therapeutically useful only if cells keep its benefits while recovering their lineage identity and function after the reprogramming factors are withdrawn. Whether the relationship between reprogramming depth and recovery differs between lineages is unknown. Using reversible, traceable Sendai-OSKM, we prospectively isolated intermediate reprogramming states from primary human fibroblasts, cytotoxic T cells, and aortic endothelial cells and followed their recovery. Outcomes diverged: fibroblasts kept a reduced DNA methylation age but retained stromal remodeling and incomplete proliferative recovery; T cells recovered only from shallow reprogramming, with enhanced effector function; endothelial cells rapidly recovered identity, kept a reduced methylation age, and markedly improved vascular function. None of this tracked iPSC derivation efficiency. Multiome and knockdown analyses identified TOX as a shared progression dependency, whereas its candidate downstream programs were predominantly lineage-specific. Partial reprogramming involves a lineage-specific tradeoff between rejuvenation and recovery that must be optimized one lineage at a time.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-12
DOI
https://doi.org/10.64898/2026.11.09.764947
Primary Topic
Pluripotent Stem Cells Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Partial reprogramming reveals lineage-specific uncoupling of rejuvenation, function, and recoverability in human cells

Akira Kunitomi, Shinya Yamanaka, Julia M. Draper, Kaho Washizu et al.
bioRxiv (Cold Spring Harbor Laboratory)
Pluripotent Stem Cells Research
preprint

Partial reprogramming reveals lineage-specific uncoupling of rejuvenation, function, and recoverability in human cells

Akira Kunitomi, Shinya Yamanaka, Julia M. Draper, Kaho Washizu, Xun Wang
preprint en

Abstract

Partial reprogramming is therapeutically useful only if cells keep its benefits while recovering their lineage identity and function after the reprogramming factors are withdrawn. Whether the relationship between reprogramming depth and recovery differs between lineages is unknown. Using reversible, traceable Sendai-OSKM, we prospectively isolated intermediate reprogramming states from primary human fibroblasts, cytotoxic T cells, and aortic endothelial cells and followed their recovery. Outcomes diverged: fibroblasts kept a reduced DNA methylation age but retained stromal remodeling and incomplete proliferative recovery; T cells recovered only from shallow reprogramming, with enhanced effector function; endothelial cells rapidly recovered identity, kept a reduced methylation age, and markedly improved vascular function. None of this tracked iPSC derivation efficiency. Multiome and knockdown analyses identified TOX as a shared progression dependency, whereas its candidate downstream programs were predominantly lineage-specific. Partial reprogramming involves a lineage-specific tradeoff between rejuvenation and recovery that must be optimized one lineage at a time.

bioRxiv (Cold Spring Harbor Laboratory)
Gladstone Institutes (US)
Gladstone Institutes, Roddenberry Foundation, L. K. Whittier Foundation, National Heart, Lung, and Blood Institute
Good health and well-being
Pluripotent Stem Cells Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon